Wang, F., Meng, F., Wong, S. C. C., Cho, W. C., Yang, S., & Chan, L. W. (2020). Combination therapy of gefitinib and miR-30a-5p may overcome acquired drug resistance through regulating the PI3K/AKT pathway in non-small cell lung cancer. Ther Adv Respir Dis.

Wang, Fengfeng, Fei Meng, Sze Chuen Cesar Wong, William C.S Cho, Sijun Yang, and Lawrence W.C Chan. "Combination Therapy of Gefitinib and MiR-30a-5p May Overcome Acquired Drug Resistance Through Regulating the PI3K/AKT Pathway in Non-small Cell Lung Cancer." Ther Adv Respir Dis 2020.

Wang, Fengfeng, et al. "Combination Therapy of Gefitinib and MiR-30a-5p May Overcome Acquired Drug Resistance Through Regulating the PI3K/AKT Pathway in Non-small Cell Lung Cancer." Ther Adv Respir Dis 2020.